JUL 19, 2020 1:10 PM PDT

Synapse-Saving Proteins Could Stave Off Alzheimer's

WRITTEN BY: Annie Lennon

Researchers at the University of Texas have identified a new subset of proteins capable of protecting synapses- the structures neurons use to communicate- from being destroyed. As synapse loss is a known contributing factor towards Alzheimer's disease and schizophrenia, the findings may inform new therapeutics. 

Loss of synapses is partially responsible for memory problems in Alzheimer's. Meanwhile, synapse losses during brain development make one more susceptible to schizophrenia. 

As children grow up, they overproduce synapses, reaching their peak number of synapses somewhere between the ages of 12 and 16. Then, between ages 16 and 20, the brain undergoes net synapse elimination as a normal part of the maturation process. 

Once in adulthood, synapse numbers stabilize, being formed and destroyed at roughly the same rate. However, in some neurological diseases, the brain overproduces complement proteins, which signal immune cells called macrophages to essentially eat synapses. This leads to excessive synapse loss and is a notable occurrence in Alzheimer's disease. 

In their research, the scientists discovered proteins that prevent this function and essentially act as 'don't eat me' signals that protect synapses from being destroyed. This follows previous studies finding that the removal of complement proteins from mice leads to protection against neurodegeneration. 

"We've known about the complement proteins, but there was no data to show that there were actually any complement inhibitors in the brain," says Dr Gek-Ming Sia, a senior author of the research. "We discovered for the first time that there are, that they affect complement activation in the brain, and that they protect synapses against complement activation."

Dr. Sia continued that the findings could explain why there is a preferential loss of specific synapses in certain diseases, and why some people are more susceptible to synapse loss. 

In future research, the researchers aim further study how much complement system biology can explain the development of psychiatric disorders, how the number of compliment inhibitors could be altered, and if this would have any clinical effects. They also want to know whether different neurons produce different compliment inhibitors capable of protecting different synapse subsets. 

 

Sources: Science DailyNature

 

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
APR 21, 2021
Drug Discovery & Development
Dietary Supplement Successfully Treats Mice with Schizophrenia
APR 21, 2021
Dietary Supplement Successfully Treats Mice with Schizophrenia
Researchers from the University of Tokyo have found that betaine, a dietary supplement found in sugar beets, reduces beh ...
MAY 06, 2021
Drug Discovery & Development
Are Hallucinations Necessary for Psychedelics to Treat Depression?
MAY 06, 2021
Are Hallucinations Necessary for Psychedelics to Treat Depression?
Many who work with psychedelics say that hallucinations, or psychedelic experiences, are an integral part of psychedelic ...
JUN 01, 2021
Immunology
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
JUN 01, 2021
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Preve ...
JUN 26, 2021
Cannabis Sciences
CBD Shows Promise for Lowering Blood Sugar
JUN 26, 2021
CBD Shows Promise for Lowering Blood Sugar
Whether or not cannabis can help manage symptoms of diabetes is unclear. While some studies support cannabis as a potent ...
JUN 28, 2021
Drug Discovery & Development
Ultra-Thin Spinal Implants Could Treat Severe Pain
JUN 28, 2021
Ultra-Thin Spinal Implants Could Treat Severe Pain
Researchers from the University of Cambridge have built a minimally invasive, ultra-thin, inflatable spinal cord stimula ...
JUL 07, 2021
Cannabis Sciences
Experts Reach Consensus on Dosing Cannabis for Chronic Pain
JUL 07, 2021
Experts Reach Consensus on Dosing Cannabis for Chronic Pain
Twenty cannabis experts from across the globe have reached a consensus on how medical cannabis may be used to treat chro ...
Loading Comments...